论文部分内容阅读
目的:观察过敏性结膜炎采用奥洛他定与思然联合治疗的临床疗效。方法:将我院收治的70例过敏性结膜炎患者按照随机数字表法分为观察组(采用奥洛他定与思然联合治疗)和对照组(单独采用奥洛他定治疗),对比观察两组患者临床治疗效果。结果:观察组患者治疗总有效率(91.4%)明显高于对照组(77.1%),差异对比具有统计学意义(P<0.05)。结论:过敏性结膜炎采用奥洛他定与思然联合治疗的临床疗效显著,可有效改善患者的临床症状,不良反应也相对较轻,是一种安全、有效的治疗方法。
Objective: To observe the clinical efficacy of olopatadine combined with SI Ran in the treatment of allergic conjunctivitis. Methods: Seventy patients with allergic conjunctivitis admitted to our hospital were divided into observation group (treated with Olopatadine and Silen) and control group (Olopatadine alone) according to random number table. Clinical efficacy of two groups of patients. Results: The total effective rate (91.4%) in the observation group was significantly higher than that in the control group (77.1%), the difference was statistically significant (P <0.05). Conclusion: Allergic conjunctivitis with olopatadine combined with SI Ran significant clinical efficacy, which can effectively improve the patient’s clinical symptoms, adverse reactions are relatively light, is a safe and effective treatment.